This report contains market size and forecasts of Diabetic Injection Instrument in global, including the following market information:
Global Diabetic Injection Instrument Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetic Injection Instrument Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Diabetic Injection Instrument companies in 2021 (%)
The global Diabetic Injection Instrument market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Disposable Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Injection Instrument include P. Bhogilal Associates, Novo Nordisk, Delfu, Medtronic, Eli Lilly, TERUM, Ganlee, Sanofi and BD, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Injection Instrument manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Injection Instrument Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Instrument Market Segment Percentages, by Type, 2021 (%)
Disposable
Reusable
Global Diabetic Injection Instrument Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Instrument Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Global Diabetic Injection Instrument Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Instrument Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Injection Instrument revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetic Injection Instrument revenues share in global market, 2021 (%)
Key companies Diabetic Injection Instrument sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Diabetic Injection Instrument sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
P. Bhogilal Associates
Novo Nordisk
Delfu
Medtronic
Eli Lilly
TERUM
Ganlee
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford